Serious hurdles stand in the way of a quick solution for Australia’s vaccine rollout squib

Demand for Pfizer is so hot worldwide that the drug giant won’t be able to dispatch the extra 20 million doses until the final quarter of this year.
Continue reading on The Sydney Morning Herald...